New hope to slow MS disability progression in major drug trial

NCT ID NCT07282574

Recruiting now Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new drug, RO7268489, can help slow the worsening of disability in adults with progressive forms of multiple sclerosis (MS) who are already taking the standard therapy ocrelizumab. About 360 participants will be randomly assigned to receive either the new drug or a placebo (inactive substance) in addition to their usual treatment. The main goal is to see if the new add-on treatment can delay the progression of symptoms like walking difficulties, hand coordination problems, and cognitive decline.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Ankara City Hospital
RECRUITING

Ankara, 06800, Turkey (Türkiye)
Centrum Medyczne Medyk
RECRUITING

Rzeszów, 35-055, Poland
Centrum Medyczne NeuroProtect
RECRUITING

Warsaw, 01-684, Poland
Centrum Medyczne Pratia Katowice I
RECRUITING

Katowice, Silesian Voivodeship, 40-081, Poland
Gazi University Medical Faculty
RECRUITING

Ankara, 06500, Turkey (Türkiye)
Hacettepe University of Medicine
RECRUITING

Ankara, 06100, Turkey (Türkiye)
Hospital Alvaro Cunqueiro
RECRUITING

Vigo, Pontevedra, 36312, Spain
Hospital Clinic de Barcelona
RECRUITING

Barcelona, 08036, Spain
Hospital Clinico San Carlos
RECRUITING

Madrid, 28040, Spain
Hospital General Universitario Gregorio Maranon
RECRUITING

Madrid, 28007, Spain
Hospital Regional Universitario de Malaga
RECRUITING

Málaga, 29010, Spain
Hospital Universitari Vall d Hebron
RECRUITING

Barcelona, 08035, Spain
Hospital Universitari i Politecnic La Fe
RECRUITING

Valencia, 46026, Spain
Hospital Universitario Quironsalud Madrid
RECRUITING

Pozuelo de Alarcón, Madrid, 28223, Spain
Hospital Universitario Virgen Macarena
RECRUITING

Seville, 41009, Spain
Hospital Universitario de la Princesa
RECRUITING

Madrid, 28006, Spain
Hospital del Mar
RECRUITING

Barcelona, 08003, Spain
Istanbul University Cerrahpasa Medical Faculty
RECRUITING

Istanbul, 34098, Turkey (Türkiye)
Istanbul University Istanbul Medical Faculty
RECRUITING

Istanbul, 34093, Turkey (Türkiye)
Kocaeli University Medical Faculty
RECRUITING

Kocaeli, Izmit, 41380, Turkey (Türkiye)
M.A. LEK A.M.Maciejowscy SC.
RECRUITING

Katowice, 40-571, Poland
NEURO-CARE Sp. z o.o. Sp. Komandytowa
RECRUITING

Katowice, Silesian Voivodeship, 40-749, Poland
Nmedis sp. z o.o.
RECRUITING

Rzeszw, Podkarpackie Voivodeship, 35-323, Poland
Optimal Clinical Trials - Central
RECRUITING

Auckland, 1010, New Zealand
Optimal Clinical Trials - Christchurch
RECRUITING

Christchurch Central City, South Island, 8011, New Zealand
Queen Elizabeth University Hospital
RECRUITING

Glasgow, Strathclyde, G51 4TF, United Kingdom
Resmedica NZOZ Kielce
RECRUITING

Kielce, 25-726, Poland
Samodzielny Publiczny Zakad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie
RECRUITING

Krakow, 31-503, Poland
Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital
RECRUITING

Istanbul, 34785, Turkey (Türkiye)
Southern Neurology
RECRUITING

Kogarah, New South Wales, 2217, Australia

Conditions

Explore the condition pages connected to this study.

PROGRESSIVE MULTIPLE SCLEROSIS